Gait analysis in advanced Parkinson's disease - Effect of levodopa and tolcapone

D. E. Shan*, S. J. Lee, L. Y. Chao, S. I. Yeh

*此作品的通信作者

研究成果: Article同行評審

32 引文 斯高帕斯(Scopus)

摘要

Objective: To determine the therapeutic effect of levodopa/benserazide and tolcapone on gait in patients with advanced Parkinson's disease. Methods: Instrumental gait analysis was performed in 38 out of 40 patients with wearing-off phenomenon during a randomized, double-blind, placebo-controlled trial of tolcapone. Results: Gait analysis disclosed a significant improvement by levodopa/benserazide in walking speed, stride length and the range of motion of hip, knee and ankle joints. At the end of the study, both the UPDRS motor scores during off-period and the percentage of off time improved significantly using tolcapone. However, gait analysis could not confirm this improvement. With respect to levodopa/benserazide effect, the reduction in rigidity correlated with improved angular excursion of the ankle, whereas the decreased bradykinesia correlated with improved stride length and angular excursion of the hip and knee joints. Conclusion: The results of our gait analysis confirmed that in parkinsonian patients with fluctuating motor symptoms levodopa/benserazide, but not tolcapone, produced a substantial improvement.

原文English
頁(從 - 到)70-75
頁數6
期刊Canadian Journal of Neurological Sciences
28
發行號1
DOIs
出版狀態Published - 2001

指紋

深入研究「Gait analysis in advanced Parkinson's disease - Effect of levodopa and tolcapone」主題。共同形成了獨特的指紋。

引用此